Well I think I already got my answer from $bill...
Printable View
Alot of the big boys already have melanoma assays, examples are the BRAF assay from Roche/Qiagen which is used for evaluating if you are suitable for a particular type of drug.
Where PEB are slightly ahead of what everyone else is doing is their use of urine as the sample, everything else is either blood/tissue. But again, their prep methods for urine have their own drawbacks.
None of them have experience in a startup diagnostics company, how many of us would get jobs we dont have experience with?
I can assure you that if they want to get to their $100m sales target and make a profit they are going to need to change their prep methods, PEB are aware of this and looking for solutions.
Currently they have to do a liquid-liquid extraction, followed by a purification with spin columns (i.e. https://www.youtube.com/watch?v=7FEbTyOXs-k)
Everyone else does this.... https://www.youtube.com/watch?v=7AOtQCY51Oc
Thanks for that.
The US lab is set up to handle 260k tests pa , the NZ lab I understood 4k pw. There are approved labs Europe and Aust. So they have the capability to process sufficient tests to crack 100m no?
No doubt there will be further developments in processing- I note the process you say everyone else is using is probably already a decade old in design. But do you agree that PEB have the capabilities to reach throughput targets at least over the next 3-4 years?
Hi robbo and winner (with these trustworthy numbers at the butt ...) - might be a good time to stop and reconsider the tone of your posts. I think it is quite rude to gang up on a fellow poster in this way - he/she is entitled to her/his view same as you are entitled to yours.
If you don't like the PEB share price to linger, than just put your money where your mouth is and buy more. Why not take the company over ... this would finish this thread (which might be a good thing)?
Personally - I think that PEB has a good product, however I don't see yet a way to value them ... and buying shares based on hype is normally the wrong thing to do.
Never understoood situation about Colorectal gen1 but others still in development Casino?Attachment 7466